Consumers can improve stroke trial design

Consumers support the idea of planned trials of thrombolysis for acute ischaemic stroke, and their involvement can help to refine consent procedures, leading to an ethically acceptable trial. Koops and Lindley (p 415) report the results of quantitative and qualitative research involving older people, stroke patients, and carers in designing a consent procedure for a trial of thrombolysis for acute ischaemic stroke. The consumers thought it appropriate that relatives, or perhaps even doctors, should give consent, and they also suggested many changes to the trial's information material.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.